Posted by Clinical Lab Products | Sep 14, 2010 | Miscellaneous |
Myconostica Ltd presented positive data from a multi-centre prospective evaluation of MycAssay Pneumocystis, the Companys CE marked diagnostic product for detection of Pneumocystis DNA in respiratory samples.
Read MorePosted by Clinical Lab Products | Jul 20, 2010 | Miscellaneous |
The FDA can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way, according to the American Clinical Laboratory Association.
Read MorePosted by Clinical Lab Products | Jul 14, 2010 | Miscellaneous |
Asuragen Inc and Life Technologies Corp announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test.
Read MorePosted by Clinical Lab Products | Jul 9, 2010 | Cancer, Miscellaneous |
Researchers at Whitehead Institute and Childrens Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients.
Read MorePosted by Clinical Lab Products | Jun 9, 2010 | Miscellaneous |
Biomerica Inc announced that it has purchased a patented technology and the manufacturing rights for a new Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of developing severe side effects.
Read More